无再流现象
摘要
随着血管再通技术的发展,急性心肌梗死的治疗也取得了实质性的进展,而无再流现象是限制血管再通技术发展的重要因素。正确理解无再流现象的发生机理,进行合理干预具有十分重要的临床意义。本文就无再流现象的研究进展作简要的综述。
出处
《浙江实用医学》
2005年第6期427-429,431,共4页
Zhejiang Practical Medicine
参考文献21
-
1Majno G, Ames A Ⅲ, Chiang J, et al. No reflow after cerebral ischaemia.Lancet, 1967,2:569
-
2Kloner R A, Ganote C E,Jennings R B. The"no - reflow"phenomenon after temporary coronary occlusion in the dog. J Clin Incest, 1974,54:1496
-
3Ito H, Okamura A, Iwakura K, et al. Myocardial perfusion patterns related to thrombo1ysis in myocardial infarction perfusion grades after coronary angioplasty in patients with acute anterior wall myocardial infarction. Circulation 1996,93:1993
-
4Byme J G, Appleyard R F, Lee C C, et al. Controlled reperfusion of the regionally ischemic myocardium with leukocyte - depleted blood reduces stunning, the no - reflow phenomenon, and infarct size. J Thorac Cardiovasc Surg, 1992,103:66
-
5Hataya Y, Matsuo K, Ishigaki M, et al. Retrograde intra - arterial infusion of prostaglandin E1 and heparin for the no - re'ow phenomenon after oromandibular reconstruction with a free fibular flap. Ann Plast Surg, 1999,42:92
-
6Golino P, Ragni M, Cirillo P, et al. Recombinant human, active site -blocked factor Vlla reduces infarct size and no- reflow phenomenon in rabbits. Am J Physiol, 2000,278: H1507
-
7Morishima I, Sone T, Okumura K, et al. Angiographic no - reflow phenomenon as a predictor of adverse long - term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction. J-Am-Coll-Cardiol, 2000,36(4): 1202
-
8Tsubokawa A, Ueda K, Sakamoto H, et al. Effect of intracoronary nicorandil administration on preventing no - reflow/slow flow phenomenon during rotational atherectomy. Circ J,2002,66(12): 1119
-
9Ito H, Taniyama Y, Iwakura K, et al. Intravenous nicorandil can preserve microvascular integrity and myocardial viability in patients with reperfused anterior wall myocardial infarction. J Am Coll Cardiol, 1999,33(3) :654
-
10Wemer GS, Lang K, Kuehnert H,et al. Intracoronary verapamil for reversal of no - reflow during coronary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv, 2002,57(4) :444
-
1周美媚,任海燕.重型颅脑损伤患者下肢深静脉血栓形成的相关因素分析[J].健康研究,2014,34(2):205-207. 被引量：7
-
2樊树雄.糖代谢异常合并冠心病患者的回顾性分析[J].内蒙古医学杂志,2010,42(S6):144-145.
-
3卞维仕,田锋,林祥辉,康振兴,武善霞.CTGF、VEGF在慢性阻塞性肺疾病吸烟患者中的相关研究[J].中国社区医师,2016,32(16):113-114. 被引量：1
-
4刘伟,李飞,王磊.血管内皮生长因子与结缔组织生长因子在慢性阻塞性肺病患者中的相关研究[J].中国医药指南,2016,14(22):26-27.
-
5蒙元劲.合理干预对代谢综合征的作用[J].齐齐哈尔医学院学报,2007,28(15):1822-1822.
-
6邓伟吾.正确理解与合理使用“社区获得性肺炎诊断和治疗指南”[J].上海交通大学学报（医学版）,2008,28(9):1057-1061. 被引量：13
-
7李娜.正确理解药品的“不良反应”[J].肝博士,2010(1):51-51.
-
8蒋旭,周勤,宋燕燕,陈启乾.糖尿病患者对牙周炎认知程度的调查分析[J].中国现代药物应用,2009,3(16):194-195.
-
9许俊堂,胡大一.正确理解心电图ST段和T波变化[J].中国临床医生杂志,2003,31(3):15-15. 被引量：8
-
10陈勇,陈云清,张仕玉.不同性别腹型肥胖人群血糖及血脂分析[J].社区医学杂志,2015,13(4):83-84. 被引量：2
